Skip to content
10-Q

Quarterly Report

ASTEX PHARMACEUTICALS, INC

0001047469-12-005756

← back to feed
Filed
May 10, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 4, 2012 93.11M sh
Stockholders Equity Q1 2012 · Mar 31, 2012 $231.58M
Stockholders Equity Q1 2012 · Dec 31, 2011 $220M
Current Liabilities Q1 2012 · Mar 31, 2012 $25.3M
Current Liabilities Q1 2012 · Dec 31, 2011 $34.67M
Total Liabilities Q1 2012 · Mar 31, 2012 $42.92M
Total Liabilities Q1 2012 · Dec 31, 2011 $56.95M
Current Assets Q1 2012 · Mar 31, 2012 $129.59M
Current Assets Q1 2012 · Dec 31, 2011 $136.57M
Total Assets Q1 2012 · Mar 31, 2012 $274.5M
Total Assets Q1 2012 · Dec 31, 2011 $276.95M
Shares Diluted Q1 2012 · Mar 31, 2011 61.03M sh
Capex Q1 2012 · Mar 31, 2011 $398K
Cash And Equivalents Q1 2012 · Mar 31, 2011 $24.82M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $25.55M
Eps Diluted Q1 2012 · Mar 31, 2011 $0.09
Eps Basic Q1 2012 · Mar 31, 2011 $0.09
Sga Expense Q1 2012 · Mar 31, 2011 $3.62M
Rd Expense Q1 2012 · Mar 31, 2011 $7.99M
Operating Income Q1 2012 · Mar 31, 2011 $5.49M
Revenue Q1 2012 · Mar 31, 2011 $17.1M